InvestogramInvestogramDeterministic scoring, no LLM judgment. Missing data stays missing — never guessed. Mainboard only.
Strictly advisory — Investogram does not apply for IPOs on your behalf.
These are fictional IPOs used to illustrate the scoring engine. They are NOT real investment opportunities.
100% Fresh Issue / Capex (12/15)
Durable competitive advantages — this business can compound capital over time.
ROE 13.4% & Profitable (16/25)
Decent but not elite profitability — sustainable, but won't compound fast.
0% OFS — strong promoter skin (18/20)
Promoters are keeping their equity — aligned with you as a shareholder.
Implied P/E 20.4x vs Peer 40.0x — deep discount (20/25)
Priced attractively vs peers — buying at a discount reduces your downside risk.
Raised ₹41.66 Cr from anchors (7/10)
Moderate institutional interest — not a conviction buy, but not a red flag.
~27% GMP over issue price (3/5)
Mixed market signals — listing gains possible but not guaranteed.
OFS-only — unclear use of proceeds (4/15)
Weak or commoditised business — unlikely to earn above-average returns long-term.
Profitable but no growth (7/25)
Weak or loss-making — high risk of future dilution or debt spiral.
OFS 85% — penalty applied (0/20)
Founders are cashing out heavily — misaligned incentives, a key red flag.
Expensive premium vs peers (0/25)
Expensive relative to peers — most upside is already priced in.
No anchor investors (0/10)
Low anchor allocation or OFS-heavy — institutions aren't excited about this one.
Stale / Weak GMP (0/5)
Weak GMP or adverse macro — poor timing for listing gains.